289 GENES FOUND

? »

« prev | Page of 6 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ATP6V1C1ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1Transporters
Expressed in all
ATP6V1E1ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1Plasma proteins
Transporters
Expressed in all
ATP6V1E2ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E2
Expressed in all
ATP6V1FATPase, H+ transporting, lysosomal 14kDa, V1 subunit FTransporters
Expressed in all
ATP6V1G1ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1Plasma proteins
Transporters
Expressed in all
ATP6V1G2ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2
Tissue enriched
ATP6V1G3ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3Transporters
Tissue enriched
ATP6V1HATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit HTransporters
Expressed in all
BAIAP2L1BAI1-associated protein 2-like 1
Mixed
BCAR1Breast cancer anti-estrogen resistance 1Plasma proteins
Predicted secreted proteins
Mixed
BDH13-hydroxybutyrate dehydrogenase, type 1Candidate cardiovascular disease genes
Enzymes
Mitochondrial proteins
Expressed in all
BSCL2Berardinelli-Seip congenital lipodystrophy 2 (seipin)Disease related genes
Predicted membrane proteins
Expressed in all
CAB39Calcium binding protein 39Plasma proteins
Expressed in all
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA2D2Calcium channel, voltage-dependent, alpha 2/delta subunit 2FDA approved drug targets
Transporters
Tissue enriched
CASRCalcium-sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CD38CD38 moleculeCancer-related genes
CD markers
Enzymes
Mixed
CDK1Cyclin-dependent kinase 1Cancer-related genes
Enzymes
Plasma proteins
Mixed
CDK16Cyclin-dependent kinase 16Enzymes
Expressed in all
CPT1ACarnitine palmitoyltransferase 1A (liver)Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Predicted membrane proteins
Expressed in all
CRKV-crk avian sarcoma virus CT10 oncogene homolog
Expressed in all
DOK2Docking protein 2, 56kDa
Mixed
DOK4Docking protein 4
Expressed in all
EIF4BEukaryotic translation initiation factor 4B
Expressed in all
EIF4EEukaryotic translation initiation factor 4ECancer-related genes
Disease related genes
Plasma proteins
Expressed in all
EIF4G1Eukaryotic translation initiation factor 4 gamma, 1Cancer-related genes
Disease related genes
Plasma proteins
Expressed in all
FABP2Fatty acid binding protein 2, intestinalCancer-related genes
Plasma proteins
Group enriched
FABP3Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)Candidate cardiovascular disease genes
Plasma proteins
Group enriched
FADS1Fatty acid desaturase 1FDA approved drug targets
Predicted membrane proteins
Expressed in all
FGF1Fibroblast growth factor 1 (acidic)Cancer-related genes
FDA approved drug targets
RAS pathway related proteins
Group enriched
FGF2Fibroblast growth factor 2 (basic)Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
RAS pathway related proteins
Mixed
FGF5Fibroblast growth factor 5Predicted secreted proteins
RAS pathway related proteins
Tissue enhanced
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FGFR3Fibroblast growth factor receptor 3Cancer-related genes
CD markers
Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
FOXA2Forkhead box A2Cancer-related genes
Transcription factors
Tissue enhanced
FOXO1Forkhead box O1Cancer-related genes
Disease related genes
Transcription factors
Expressed in all
FOXO3Forkhead box O3Cancer-related genes
Disease related genes
Transcription factors
Expressed in all
FOXO4Forkhead box O4Cancer-related genes
Disease related genes
RAS pathway related proteins
Transcription factors
Tissue enriched
FRS3Fibroblast growth factor receptor substrate 3
Mixed
GAD1Glutamate decarboxylase 1 (brain, 67kDa)Disease related genes
Enzymes
Potential drug targets
Tissue enriched
GAD2Glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)Enzymes
Tissue enriched
GLULGlutamate-ammonia ligaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Expressed in all
GNASGNAS complex locusCancer-related genes
Disease related genes
Predicted secreted proteins
Expressed in all
HADHAHydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunitDisease related genes
Enzymes
Mitochondrial proteins
Plasma proteins
Potential drug targets
Expressed in all
HDAC5Histone deacetylase 5Cancer-related genes
Enzymes
Expressed in all
HDAC9Histone deacetylase 9Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HIF1AHypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)Cancer-related genes
Plasma proteins
Transcription factors
Expressed in all
HLA-DRB1Major histocompatibility complex, class II, DR beta 1Disease related genes
Plasma proteins
Predicted membrane proteins
Expressed in all
HMGCR3-hydroxy-3-methylglutaryl-CoA reductaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
HMGN3High mobility group nucleosomal binding domain 3
Expressed in all

« prev | Page of 6 | next »